What is the main business of Imunotop Pl?

The main business activity of Imunotop Pl focuses on non-specialised wholesale of food, beverages and tobacco.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 17, 2003.

Where is the headquarters located?

The headquarters is located at: ul. Mikołaja Gogola 12, 92-513 Łódź.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $128,778 in 2024, which is an increase of 18.5% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $803, meaning the company increased its profit by 174.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $80,275 in 2024, representing 64% of all operating expenses.

Imunotop Plsp. z o.o.

Non-specialised wholesale of food, beverages and tobacco

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2003-02-17

Share capital

50,000.00 PLN

Activity description

Imunotop Pl is a distributor of Bi.Bran (BioBran), a dietary supplement containing MGN-3 Arabinoxylan, in Poland. The company offers various packaging options, including tablets and sachets, with specific dosages for consumer use. Bi.Bran is registered with the Chief Sanitary Inspectorate in Poland.

Registered address

ul. Mikołaja Gogola 12, 92-513 Łódź, Poland

Website

imunotop.pl

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 136 days for 2023).

2025not filed
202414/10/2025
202328/11/2024
202226/10/2023
202117/10/2022
202013/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 128.78kMedianUSD 1.02mAverageUSD 16.03m

Net profit

This companyUSD 803.05MedianUSD 21.03kAverageUSD 367.26k

Operating costs

This companyUSD 125.27kMedianUSD 984.65kAverageUSD 15.56m

Assets

This companyUSD 33.31kMedianUSD 400.67kAverageUSD 5.75m

Industry

Offer

Dietary supplement tablets
Dietary supplement sachets

Authorized Representatives

Grzegorz Jan Krzanowski – President of the Management Board

Zbigniew Tadeusz Ryngajłło – Vice President of the Management Board

Manner of representation

Each member of the management board has the right to represent the company on a one-person basis.

Ownership

Owner	Shares	Share value	Stake
Grzegorz Jan Krzanowskiage 54	67	$9,049.16	67%
Zbigniew Tadeusz Ryngajłłoage 62	33	$4,457.05	33%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2005-09-29.

mBank
57 1140 2017 0000 4702 0489 0895

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $12,937.

Grant date	Purpose	Gross amount	Granting body
Apr 23, 2021	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$2,184$2,184	Prezydent Miasta Łódź
Jul 31, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$7,693$7,693	Polski Fundusz Rozwoju S.A.
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$435$435	Prezes Zakładu Ubezpieczeń Społecznych

Competitors

Name	Revenue	Website
Polsil Biopreparatysp. z o.o.	$952,024.30	polsil.pl
Performance Group Polandsp. z o.o.	$839,700.14	pgpoland.com
Madmedsp. z o.o.	$426,323.50	madmed.eu
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
NutrisleP.S.A.	$135,614.44	nutrisle.com
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com
Terezia Polskasp. z o.o.	$57,221.46	terezia.eu

Change history

Date	Event
2020-12-09	Address change (Węgierska 5/16, 92-314, Łódź → Ul. Mikołaja Gogola 12, 92-513, Łódź)
2020-12-09	Switch to PKD 2007 (67 PKD 1997 codes → 10 PKD 2007 codes)
2005-09-23	Address change (Opłotki 8, 98-200, Sieradz → Węgierska 5/16, 92-314, Łódź)
2005-09-23	PKD change (Added: 71.10.Z, 71.21.Z)
2003-02-17	Entered in the register

FAQ

Last updated: 2026-06-08